{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:53:39Z","timestamp":1792641219857,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2008,1,5]],"date-time":"2008-01-05T00:00:00Z","timestamp":1199491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12016-007-8071-9","type":"journal-article","created":{"date-parts":[[2008,1,4]],"date-time":"2008-01-04T14:49:03Z","timestamp":1199458143000},"page":"47-58","source":"Crossref","is-referenced-by-count":48,"title":["Antineutrophil Cytoplasmic Autoantibodies: How Should the Biologist Manage Them?"],"prefix":"10.1007","volume":"35","author":[{"given":"C.","family":"Beauvillain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Delneste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Renier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Subra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chevailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,5]]},"reference":[{"key":"8071_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","volume":"1","author":"FJ Woude van der","year":"1985","unstructured":"van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH (1985) Antibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis. Lancet 1:425\u2013429","journal-title":"Lancet"},{"key":"8071_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/berh.2000.0140","volume":"15","author":"N Mohan","year":"2001","unstructured":"Mohan N, Kerr GS (2001) Best Pract Res Clin Rheumatol 15:203\u2013223","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8071_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"8071_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","volume":"285","author":"DJ Davies","year":"1982","unstructured":"Davies DJ, Moran JE, Niall JF, Ryan GB (1982) Segmental necrotizing glomerulonephritis with anti-neutrophil antibody: possible arbovirus aetiology? Br Med J 285:606","journal-title":"Br Med J"},{"key":"8071_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.berh.2004.10.003","volume":"19","author":"J Savige","year":"2005","unstructured":"Savige J, Pollock W, Trevisin M (2005) What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol 19:263\u2013276","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8071_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s002810100074","volume":"23","author":"IM Bajema","year":"2001","unstructured":"Bajema IM, Hagen EC, Ferrario F, de Heer E, Bruijn JA (2001) Immunopathological aspects of systemic vasculitis. Springer Semin Immunopathol 23:253\u2013265","journal-title":"Springer Semin Immunopathol"},{"key":"8071_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/labinvest.3780067","volume":"80","author":"V Witko-Sarsat","year":"2000","unstructured":"Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80:617\u2013653","journal-title":"Lab Invest"},{"key":"8071_CR8","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115\u20134119","journal-title":"Proc Natl Acad Sci USA"},{"key":"8071_CR9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1172\/JCI119662","volume":"100","author":"DR Ralston","year":"1997","unstructured":"Ralston DR, Marsh CB, Lowe MP, Wewers MD (1997) Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 100:1416\u20131424","journal-title":"J Clin Invest"},{"key":"8071_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2249.2006.03179.x","volume":"146","author":"AS Lee","year":"2006","unstructured":"Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Jacob GL, Homburger HA, Specks U, Wegener\u2019s Granulomatosis Etanercept Trial Research Group (2006) Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma. Clin Exp Immunol 146:15\u201320","journal-title":"Clin Exp Immunol"},{"key":"8071_CR11","first-page":"12","volume":"97","author":"A Wiik","year":"1989","unstructured":"Wiik A (1989) Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Scand 97:12\u201313","journal-title":"Acta Pathol Microbiol Scand"},{"key":"8071_CR12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651\u20131657","journal-title":"N Engl J Med"},{"key":"8071_CR13","first-page":"1","volume-title":"Manual of biological markers of diseases","author":"A Wiik","year":"1994","unstructured":"Wiik A, Rasmussen N, Wieslander J (1994) Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht A9, pp 1\u201314"},{"key":"8071_CR14","first-page":"1","volume-title":"ANCA antigens: myeloperoxydase","author":"J Wieslander","year":"1994","unstructured":"Wieslander J, Wiik A (1994) ANCA antigens: myeloperoxydase. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.2, pp 1\u20139"},{"key":"8071_CR15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/jcp.51.8.568","volume":"51","author":"JA Savige","year":"1998","unstructured":"Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M (1998) A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 51:568\u2013575","journal-title":"J Clin Pathol"},{"key":"8071_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-1759(12)80034-2","volume":"147","author":"A Chevailler","year":"1992","unstructured":"Chevailler A, Noel LH, Renier G, Gardembas-Pain M, Subra JF, Nusbaum P, Hurez D, Lesavre P (1992) Unambiguous determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells. J Immunol Methods 147:101\u2013109","journal-title":"J Immunol Methods"},{"key":"8071_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"J Savige","year":"1999","unstructured":"Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 111:507\u2013513","journal-title":"Am J Clin Pathol"},{"key":"8071_CR18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2169\/internalmedicine.40.466","volume":"40","author":"A Wiik","year":"2001","unstructured":"Wiik A (2001) Anti-neutrophil cytoplasmic antibodies tests: which tests should be used in practice? Internal Med 40:446\u2013470","journal-title":"Internal Med"},{"key":"8071_CR19","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI113816","volume":"82","author":"RC Kao","year":"1988","unstructured":"Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR (1988) A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamster. J Clin Invest 82:1963\u20131973","journal-title":"J Clin Invest"},{"key":"8071_CR20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","volume":"84","author":"R Goldschmeding","year":"1989","unstructured":"Goldschmeding R, van der Schoot CE, ten Bokkell Huinink D, Hack CE, van den Ende ME, Kallenberg CGM, von dem Borne AE (1989) Wegener\u2019s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577\u20131587","journal-title":"J Clin Invest"},{"key":"8071_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","volume":"69","author":"YM Geld van der","year":"2001","unstructured":"van der Geld YM, Limburg PC, Kallenberg CGM (2001) Proteinase 3, Wegener\u2019s autoantigen: from gene to antigen. J Leukoc Biol 69:177\u2013190","journal-title":"J Leukoc Biol"},{"key":"8071_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002810100076","volume":"23","author":"A Wiik","year":"2001","unstructured":"Wiik A (2001) Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommandation for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results. Springer Semin Immunopathol 23:217\u2013229","journal-title":"Springer Semin Immunopathol"},{"key":"8071_CR23","first-page":"1","volume-title":"ANCA antigens: proteinase 3","author":"J Wieslander","year":"1994","unstructured":"Wieslander J, Wiik A (1994) ANCA antigens: proteinase 3. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.1, pp 1\u20139"},{"key":"8071_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-044482383-0\/50011-X","volume-title":"Autoantibodies","author":"WL Gross","year":"1996","unstructured":"Gross WL, Csernok E, Szymkowiak CH (1996) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 61\u201367"},{"key":"8071_CR25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2249.1998.00730.x","volume":"114","author":"J Sun","year":"1998","unstructured":"Sun J, Fass DN, Viss MA, Hummel AM, Tang H, Homburger HA, Specks U (1998) A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide. Clin Exp Immunol 114:320\u2013326","journal-title":"Clin Exp Immunol"},{"key":"8071_CR26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002810100078","volume":"23","author":"MEJ Taekema-Roelvink","year":"2001","unstructured":"Taekema-Roelvink MEJ, van Kooten C, Verburgh CA, Daha MR (2001) Role of proteinase 3 in activation of endothelium. Springer Semin Immunopathol 23:299\u2013314","journal-title":"Springer Semin Immunopathol"},{"key":"8071_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-5793(95)01073-N","volume":"374","author":"L Halbwachs-Mecarelli","year":"1995","unstructured":"Halbwachs-Mecarelli L, Bessou G, Lesavre P, Lopez S, Witko-Sarsat V (1995) Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 374:29\u201333","journal-title":"FEBS Lett"},{"key":"8071_CR28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","volume":"10","author":"V Witko-Sarsat","year":"1999","unstructured":"Witko-Sarsat V, Lesavre P, Lopez S, Bessou G, Hieblot C, Prum B, No\u00ebl LH, Guillevin L, Ravaud P, Sermet-Gaudelus I, Timsit J, Gr\u00fcnfeld JP, Halbwachs-Mecarelli L (1999) A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10:1224\u20131233","journal-title":"J Am Soc Nephrol"},{"key":"8071_CR29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/ki.1993.186","volume":"43","author":"VL Esnault","year":"1993","unstructured":"Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesbo\u00fc\u00e9 R, Martin JP, Lesavre P (1993) Alpha1-anti-trypsin genetic polymorphism in ANCA positive systemic vasculitis. Kidney Int 43:1323\u20131332","journal-title":"Kidney Int"},{"key":"8071_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/16.1.39","volume":"16","author":"MA Audrain","year":"2001","unstructured":"Audrain MA, Sesboue R, Baranger TAR, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL (2001) Analysis of anti-neutrophil antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha-1-antitrypsin-deficient subjects. Nephrol Dial Transplant 16:39\u201344","journal-title":"Nephrol Dial Transplant"},{"key":"8071_CR31","first-page":"1","volume-title":"Manual of biological markers of diseases","author":"J Wieslander","year":"1994","unstructured":"Wieslander J, Wiik A (1994) ANCA antigens: myeloperoxidase. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.2, pp 1\u20139"},{"key":"8071_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-044482383-0\/50010-8","volume-title":"Autoantibodies","author":"CGM Kallenberg","year":"1996","unstructured":"Kallenberg CGM (1996) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 53\u201360"},{"key":"8071_CR33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-044452763-9\/50017-2","volume-title":"Autoantibodies","author":"CGM Kallenberg","year":"2007","unstructured":"Kallenberg CGM (2007) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 95\u2013103"},{"key":"8071_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-1759(01)00392-1","volume":"254","author":"MM Boomsma","year":"2001","unstructured":"Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CGM, Moguilevsky N, Limburg PC, Tervaert JW (2001) Native and recombinant proteins to analyze autoantibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J Immunol Methods 254:47\u201358","journal-title":"J Immunol Methods"},{"key":"8071_CR35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.1992.tb06944.x","volume":"89","author":"RJ Falk","year":"1992","unstructured":"Falk RJ, Becker M, Terrell R, Jennette JC (1992) Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol 89:274\u2013278","journal-title":"Clin Exp Immunol"},{"key":"8071_CR36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2249.1994.tb06051.x","volume":"96","author":"M Segelmark","year":"1994","unstructured":"Segelmark M, Baslund B, Wieslander J (1994) Some patients with antimyeloperoxidase autoantibodies have a cANCA pattern. Clin Exp Immunol 96:458\u2013465","journal-title":"Clin Exp Immunol"},{"key":"8071_CR37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4757-9182-2_39","volume-title":"ANCA- associated vasculitides: immunological and clinical aspects","author":"A Chevailler","year":"1993","unstructured":"Chevailler A, Subra JF, Renier G, Carr\u00e8re F, Hurez D (1993) Anti-myeloperoxidase antibodies and associated diseases. In: Gross WL (ed) ANCA- associated vasculitides: immunological and clinical aspects. Plenum Press, New York, pp 263\u2013266"},{"key":"8071_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, L\u00fcdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ (1998) The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Results of an international collaborative study. Kidney Int 53:743\u2013753","journal-title":"Kidney Int"},{"key":"8071_CR39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/B978-044482383-0\/50012-1","volume-title":"Autoantibodies","author":"MH Zhao","year":"1996","unstructured":"Zhao MH, Lockwood CM (1996) Antineutrophil cytoplasmic autoantibodies with specificity other than PR3 and MPO (x-ANCA). In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 68\u201373"},{"key":"8071_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2249.1995.tb03471.x","volume":"99","author":"MH Zhao","year":"1995","unstructured":"Zhao MH, Jones SJ, Lockwood CM (1995) Bactericidal\/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 99:49\u201356","journal-title":"Clin Exp Immunol"},{"key":"8071_CR41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1189\/jlb.69.4.505","volume":"69","author":"H Schultz","year":"2001","unstructured":"Schultz H, Weiss J, Carroll SF, Gross WL (2001) The endotoxin bactericidal\/permeability increasing protein (BPI): a target of autoantibodies. J Leukoc Biol 69:505\u2013512","journal-title":"J Leukoc Biol"},{"key":"8071_CR42","first-page":"629","volume":"18","author":"M Segelmark","year":"2000","unstructured":"Segelmark M, Westman K, Wieslander J (2000) How and why should we detect ANCA? Clin Exp Rheumatol 18:629\u2013635","journal-title":"Clin Exp Rheumatol"},{"key":"8071_CR43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2249.1996.tb08293.x","volume":"103","author":"MH Zhao","year":"1996","unstructured":"Zhao MH, Lockwood CM (1996) Azurocidin is a novel antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in systemic vasculitis. Clin Exp Immunol 103:397\u2013402","journal-title":"Clin Exp Immunol"},{"key":"8071_CR44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(89)91420-7","volume":"1","author":"L Nassberger","year":"1989","unstructured":"Nassberger L, Jonsson H, Sjoholm AG, Sturfelt G, Heubner A (1989) Circulating antielastase in systemic lupus erythematosus. Lancet 1:509","journal-title":"Lancet"},{"key":"8071_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.1992.tb05835.x","volume":"90","author":"L Halbwachs-Mecarelli","year":"1992","unstructured":"Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Gr\u00fcnfeld JP, Lesavre P (1992) Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn\u2019s disease and primary sclerosing cholangitis. Clin Exp Immunol 90:79\u201384","journal-title":"Clin Exp Immunol"},{"key":"8071_CR46","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/art.1780351210","volume":"35","author":"IE Corremans","year":"1992","unstructured":"Corremans IE, Hagen EC, Daha MR, van der Voort EA, Kleijburg-van der Keur C, Breedveld FC (1992) Antilactoferrin antibodies in patients with arthritis are associated with vasculitis. Arthritis Rheum 35:1466\u20131475","journal-title":"Arthritis Rheum"},{"key":"8071_CR47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.182.1.41","volume":"182","author":"MY Gallin","year":"1995","unstructured":"Gallin MY, Jacobi AB, Buttner DW, Schoenberger O, Marti T, Ertman KDA (1995) Human autoantibody to defensin: disease association with hyperactive onchocerciasis. J Exp Med 182:41\u201347","journal-title":"J Exp Med"},{"key":"8071_CR48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4757-9182-2_40","volume-title":"ANCA- associated vasculitides: immunological and clinical aspects","author":"WH Schmitt","year":"1993","unstructured":"Schmitt WH, Csernok E, Flesch BK, Hauschild S, Gross WL (1993) Autoantibodies directed against lysozyme: a new target antigen for antineutrophil cytoplasmic antibodies (ANCA). In: Gross WL (ed) ANCA- associated vasculitides: immunological and clinical aspects. Plenum Press, New York, pp 267\u2013272"},{"key":"8071_CR49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0140-6736(92)92279-O","volume":"340","author":"L Nassberger","year":"1992","unstructured":"Nassberger L, Ljungh A, Schumacher G, Kollberg B (1992) \u03b2-glucuronidase in ulcerative colitis. Lancet 340:734\u2013735","journal-title":"Lancet"},{"key":"8071_CR50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1993.97","volume":"43","author":"FD Moodie","year":"1993","unstructured":"Moodie FD, Leaker B, Cambridge G, Totty NF, Segal AW (1993) Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int 43:675\u2013681","journal-title":"Kidney Int"},{"key":"8071_CR51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.181.2.585","volume":"181","author":"R Kain","year":"1995","unstructured":"Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D (1995) A novel class of autoantigens of antineutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granules and a related membrane proteine in glomerular endothelial cells. J Exp Med 181:585\u2013597","journal-title":"J Exp Med"},{"key":"8071_CR52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03453.x","volume":"150","author":"MV Talor","year":"2007","unstructured":"Talor MV, Stone JH, Stebbing J, Barin J, Rose NR, Burek CL (2007) Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 150:42\u201348","journal-title":"Clin Exp Immunol"},{"key":"8071_CR53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, L\u00fcdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ (1998) The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Results of an international collaborative study. Kidney Int 53:743\u2013753","journal-title":"Kidney Int"},{"key":"8071_CR54","first-page":"143","volume":"78","author":"FJ Woude van der","year":"1989","unstructured":"van der Woude FJ, Daha MR, van Es LA (1989) The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol 78:143\u2013148","journal-title":"Clin Exp Immunol"},{"key":"8071_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(93)90136-U","volume":"159","author":"EC Hagen","year":"1993","unstructured":"Hagen EC, Andrassy K, Chernok E, Daha MR, Gaskin G, Gross W, Lesavre P, L\u00fcdemann J, Pusey CD, Rasmussen N et al (1993) The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 159:1\u201316","journal-title":"J Immunol Methods"},{"key":"8071_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(96)00111-1","volume":"196","author":"EC Hagen","year":"1996","unstructured":"Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross W, Hansen B, Heigl Z, Hermans J, Jayne D, Kallenberg CG, Lesavre P, Lockwood CM, L\u00fcdemann J, Mascart-Lemone F, Mirapeix E, Pusey CD, Rasmussen N, Sinico RA, Tzioufas A, Wieslander J, Wiik A, Van der Woude FJ (1996) Development of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the stardardization of ANCA assays. J Immunol Methods 196:1\u201315","journal-title":"J Immunol Methods"},{"key":"8071_CR57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-1759(98)00203-8","volume":"222","author":"MA Audrain","year":"1999","unstructured":"Audrain MA, Reumaux D, Gerson F, Duthilleul P, Wiik A, Muller JY, Esnault VL (1999) Contamination of commercially purified myeloperoxidase preparations by lactoferrin. J Immunol Methods 222:219\u2013220","journal-title":"J Immunol Methods"},{"key":"8071_CR58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01325.x","volume":"121","author":"HS Jethwa","year":"2000","unstructured":"Jethwa HS, Nachman PH, Falk RJ, Jennette JC (2000) False-positive myeloperoxidase binding activity due to DNA\/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol 121:544\u2013550","journal-title":"Clin Exp Immunol"},{"key":"8071_CR59","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1523-1755.1998.00873.x","volume":"53","author":"KW Westman","year":"1998","unstructured":"Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J (1998) Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 53:1230\u20131236","journal-title":"Kidney Int"},{"key":"8071_CR60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1196\/annals.1398.051","volume":"1109","author":"J Damoiseaux","year":"2007","unstructured":"Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Cohen Tervaert JW (2007) Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture\u2019s disease. Ann N Y Acad Sci 1109:454\u2013463","journal-title":"Ann N Y Acad Sci"},{"key":"8071_CR61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ajcp\/111.3.363","volume":"111","author":"L Lim","year":"1999","unstructured":"Lim L, Taylor J, Schmitz J, Folds J, Wilkman A, Falk RJ, Jennette JC (1999) Diagnostic usefulness of antineutrophil cytoplasmic antibody serology. Am J Clin Path 111:363\u2013369","journal-title":"Am J Clin Path"},{"key":"8071_CR62","first-page":"15","volume":"49","author":"JF Subra","year":"1998","unstructured":"Subra JF, Michelet C, Laporte J, Carrere F, Reboul P, Cartier F, Saint-Andr\u00e9 JP, Chevailler A (1998) The presence of cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincedence or association? Clin Nephrol 49:15\u201318","journal-title":"Clin Nephrol"},{"key":"8071_CR63","first-page":"203","volume":"12","author":"A Soto","year":"1994","unstructured":"Soto A, Jorgensen C, Oksman F, Noel LH, Sany J (1994) Endocarditis associated with ANCA. Clin Exp Rheumatol 12:203\u2013204","journal-title":"Clin Exp Rheumatol"},{"key":"8071_CR64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjmed.2006.08.016","volume":"120","author":"JD Finkielman","year":"2007","unstructured":"Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U, WGET Research Group (2007) ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis. Am J Med 120:643","journal-title":"Am J Med"},{"key":"8071_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","volume":"43","author":"HK Choi","year":"2000","unstructured":"Choi HK, Merkel PA, Walker AM, Niles JL (2000) Drug-associated antineutrophil cytoplasmic antibodies-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43:405\u2013413","journal-title":"Arthritis Rheum"},{"key":"8071_CR66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0272-6386(95)90098-5","volume":"25","author":"J De\u2019Oliviera","year":"1995","unstructured":"De\u2019Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD (1995) Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 25:380\u2013389","journal-title":"Am J Kidney Dis"},{"key":"8071_CR67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","volume":"336","author":"JW Cohen-Tervaert","year":"1990","unstructured":"Cohen-Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CG (1990) Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on anti-neutrophil cytoplasmic antibodies titre. Lancet 336:709\u2013711","journal-title":"Lancet"},{"key":"8071_CR68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","volume":"36","author":"GS Kerr","year":"1993","unstructured":"Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS (1993) Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener\u2019s granulomatosis. Arthritis Rheum 36:365\u2013371","journal-title":"Arthritis Rheum"},{"key":"8071_CR69","doi-asserted-by":"crossref","unstructured":"Mukhtyar C, Flossmann O, Hellmich B, Bacon PA, Cid MC, Cohen Tervaert JW, Gross WL, Guillevin L, Jayne DR, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA (2007) Outcomes from studies of Antineutrophil Cytoplasm Antibody Associated Vasculitis: a systematic review by the EULAR Systemic Vasculitis Task Force. Ann Rheum Dis Oct 2; [Epub ahead of print]","DOI":"10.1136\/ard.2007.071936"},{"key":"8071_CR70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jcp.2003.8052","volume":"57","author":"D Sinclair","year":"2004","unstructured":"Sinclair D, Saas M, Stevens JM (2004) The effect of a symptom related \u201cgating policy\u201d on ANCA requests in routine clinical practice. J Clin Pathol 57:131\u2013134","journal-title":"J Clin Pathol"},{"key":"8071_CR71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002810100079","volume":"23","author":"CA Stegeman","year":"2001","unstructured":"Stegeman CA, Kallenberg CGM (2001) Clinical aspects of primary vasculitis. Springer Semin Immunopathol 23:231\u2013251","journal-title":"Springer Semin Immunopathol"},{"key":"8071_CR72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-044452763-9\/50018-4","volume-title":"Autoantibodies","author":"A Radice","year":"2007","unstructured":"Radice A, Sabadini E, Sinico RA (2007) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 105\u2013110"},{"key":"8071_CR73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-044452763-9\/50020-2","volume-title":"Autoantibodies","author":"P Aries","year":"2007","unstructured":"Aries P, Csernok E, Gross L (2007) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 119\u2013126"},{"key":"8071_CR74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","volume":"10","author":"WF Pendergraft 3rd","year":"2004","unstructured":"Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, Falk RJ (2004) Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72\u201379","journal-title":"Nat Med"},{"key":"8071_CR75","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/ard.53.11.781-b","volume":"53","author":"A Chevailler","year":"1994","unstructured":"Chevailler A, Carr\u00e8re F, Renier G, Hurez D, Subra JF, Reboul P, Riberi P, Masson C (1994) Silicon nephropathy and myeloperoxydase antibodies. Ann Rheum Dis 53:781\u2013782","journal-title":"Ann Rheum Dis"},{"key":"8071_CR76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02828275","volume":"15","author":"G Gregorini","year":"1997","unstructured":"Gregorini G, Tira P, Frizza J, D\u2019Haese PC, Elseviers MM, Nuyts G, Maiorca R, De Broe ME (1997) ANCA-associated diseases and silica exposure. Clin Rev Allergy Immunol 15:21\u201340","journal-title":"Clin Rev Allergy Immunol"},{"key":"8071_CR77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.03501006","volume":"2","author":"SL Hogan","year":"2007","unstructured":"Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, Jennette CE, Lionaki S, Jennette JC, Falk RJ (2007) Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol 2:290\u2013299","journal-title":"Clin J Am Soc Nephrol"},{"key":"8071_CR78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s002810100077","volume":"23","author":"ME Griffith","year":"2001","unstructured":"Griffith ME, Pusey CD (2001) Cellular aspects of vasculitis\u2013 T cell-mediated aspects. Springer Semin Immunopathol 23:287\u2013298","journal-title":"Springer Semin Immunopathol"},{"key":"8071_CR79","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1365-2249.2001.01696.x","volume":"126","author":"JF Subra","year":"2001","unstructured":"Subra JF, Renier G, Reboul P, Tollis F, Boivinet R, Schwartz P, Chevailler A (2001) Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol 126:540\u2013544","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-8071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8071-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T17:35:32Z","timestamp":1684172132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-8071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,5]]},"references-count":79,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["8071"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8071-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,5]]}}}